Other options available after FDA pulls permission for 2 monoclonal antibody treatments

Two popular monoclonal antibody treatments are being shelved after the FDA pulled back its permission for their use. They say it's because the treatments aren't effective against the omicron variant. But tonight, despite some uncertainty we're learning that there are other options out there.